Description

Description

Lina-Met (2.5mg/500mg) is a combination oral medication for type 2 diabetes, bringing together Linagliptin and Metformin in a single tablet to offer a more comprehensive approach to blood sugar management. Each pack contains 14 tablets, providing patients with a convenient two-in-one option rather than taking two separate medications throughout the day. This combination is often prescribed when Metformin alone hasn’t provided sufficient blood sugar control, or when a doctor determines that a dual-action approach would better suit a patient’s needs from the start of treatment. By combining Linagliptin’s role in supporting the body’s natural insulin response with Metformin’s well-established ability to reduce liver glucose production, Lina-Met offers a more rounded strategy for managing blood sugar alongside a healthy diet and consistent exercise.

Ingredients

Each Lina-Met 2.5mg/500mg tablet contains two active ingredients: Linagliptin at a 2.5mg strength and Metformin Hydrochloride at a 500mg strength. Linagliptin belongs to the DPP-4 inhibitor class of medications, working by increasing levels of incretin hormones in the body, which help the pancreas release more insulin, particularly after meals, while also signaling the liver to reduce excess glucose production. Metformin, from the biguanide class, works through a different pathway, primarily reducing the amount of sugar the liver releases into the bloodstream, decreasing how much sugar the intestines absorb, and helping the body respond more effectively to its own insulin.

Dosage Form

Lina-Met 2.5mg/500mg is supplied as an oral tablet, packaged in a strip format containing 14 tablets, designed for regular use as part of an ongoing diabetes treatment plan.

Uses

Lina-Met 2.5mg/500mg is used, together with a proper diet and exercise program, to help control high blood sugar levels in adults with type 2 diabetes mellitus. It is not intended for the treatment of type 1 diabetes. This combination is commonly prescribed for patients who haven’t achieved adequate blood sugar control on Metformin alone, offering the added benefit of Linagliptin’s incretin-based mechanism to further support healthy glucose regulation, particularly around meal times. By addressing blood sugar from two different angles, this medication helps many patients achieve more stable glycemic control, supporting better long-term health outcomes and reducing the risk of complications tied to poorly managed diabetes.

How to Use

Lina-Met 2.5mg/500mg is typically taken with meals, often twice daily, to help reduce the likelihood of stomach-related side effects associated with the Metformin component. Your doctor may start you on this dose and gradually adjust it over time based on how well your blood sugar responds to treatment. The tablet should be swallowed whole with a glass of water and should not be crushed or chewed. Before starting this medication and with each refill, it’s worth reviewing any medication guide provided by your pharmacist, as it contains helpful reminders about proper use. Consistency is key with this medication, so taking it at the same times each day alongside a steady meal schedule supports more reliable blood sugar control.

Side Effects

Lina-Met 2.5mg/500mg can cause side effects in some patients, including nausea, diarrhea, stomach discomfort, and altered taste, particularly during the first few weeks as the body adjusts to the Metformin component. Hypoglycemia is possible, especially if this medication is combined with other diabetes treatments, so patients should be familiar with symptoms like sweating, shakiness, or confusion. A rare but serious risk associated with the Metformin component is a condition called lactic acidosis, which is more likely in older adults or those with kidney or liver disease, dehydration, heart failure, or heavy alcohol use. Symptoms of lactic acidosis include unusual tiredness, dizziness, severe drowsiness, chills, cold or bluish skin, muscle pain, difficulty breathing, an irregular heartbeat, or stomach pain accompanied by nausea or vomiting, and require immediate medical attention if they occur. Your doctor may advise temporarily stopping this medication before certain procedures, such as surgery or imaging scans involving contrast dye, due to this risk.

Pregnancy & Breastfeeding

The safety of Lina-Met 2.5mg/500mg during pregnancy has not been well established, so it’s important to inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding, so that a suitable treatment approach can be discussed. Diabetes management during pregnancy often requires a different treatment strategy, and your doctor can help guide you toward the most appropriate option for your specific situation. Because components of this medication may pass into breast milk, breastfeeding mothers should also consult their doctor before use.

Storage Instructions

Store Lina-Met 2.5mg/500mg tablets in a cool, dry place, away from direct sunlight and excess moisture. Keep the tablets in their original packaging until ready for use to help preserve their effectiveness. Store this medication safely out of reach of children and pets, and dispose of any unused or expired tablets responsibly rather than through household waste.

FAQs

Why is Lina-Met prescribed instead of Metformin alone?
This combination is often used when Metformin alone hasn’t provided sufficient blood sugar control, adding Linagliptin’s incretin-based effect for more comprehensive glucose management.

Should I take this medication with food?
Yes, taking Lina-Met with meals helps reduce the risk of stomach-related side effects associated with the Metformin component.

What symptoms should prompt me to stop taking this medication and seek help?
Symptoms of lactic acidosis, such as unusual tiredness, difficulty breathing, muscle pain, or stomach discomfort with nausea, require you to stop the medication and seek immediate medical attention.

Will I need to stop this medication before surgery?
Your doctor may advise temporarily pausing this medication before certain procedures, particularly those involving contrast dye or surgery, due to the rare risk of lactic acidosis.

Can this medication be used for type 1 diabetes?
No, Lina-Met is intended specifically for type 2 diabetes and is not suitable for patients with type 1 or insulin-dependent diabetes.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.